OBJ (ASX:OBJ) - CEO, Paul Peros - The Market Herald

" OBJ (ASX:OBJ) to raise $4.5M for product development and licencing

Innovative wellness company OBJ (OBJ) is aiming to raise $4.5 million through an entitlement offer and placement for licencing, development and general workin…
Creso Pharma (ASX:CPH) - CEO & Co Founder, Dr Miri Halperin Wernli (left) and Chairman, Boaz Wachtel (right) - The Market Herald

" Creso Pharma (ASX:CPH) subsidiary receives follow-up order from Univo Pharmaceuticals

Creso Pharma’s (CPH) subsidiary, Mernova Medicinal, has received a US$625,690 (roughly A$901,830) purchase order from Univo Pharmaceuticals.
Cellmid (ASX:CDY) - CEO, Maria Halasz (right) - The Market Herald

" Cellmid (ASX:CDY) signs distribution agreement for SARS-CoV-2 and ELISA’s

Cellmid (CDY) has signed a distribution agreement with Immunodiagnostics (IMD) for Enzyme Linked Immunosorbent Assays (ELISA’s) and SARS-CoV-2 tests in Australia and New
MyFiziq (ASX:MYQ) - CEO & Executive Director, Vlado Bosanac - The Market Herald

" MyFiziq (ASX:MYQ) receives third payment for Nasdaq listing

MyFiziq (MYQ) has received a payment of US$450,000 (around A$644,000) under the convertible note subscription deed with Asia Cornerstone Asset Management.
Holista Colltech (ASX:HCT) - Managing Director, Dr Rajen Manicka - The Market Herald

" Holista CollTech (ASX:HCT) misses the mark for hand sanitiser product

Holista CollTech (HCT) has downgraded its $3.8 million in expected sales from its hand sanitiser product, Natshield, due to COVID-19 and race riots.
LBT Innovations (ASX:LBT) - CEO & Managing Director, Brent Barnes - The Market Herald

" LBT Innovations (ASX:LBT) receives $8M placement commitments

LBT Innovations (LBT) has received firm commitments from sophisticated and professional investors to raise $8 million via a share placement.
Incannex Healthcare (ASX:IHL) - CEO, Joel Latham - The Market Herald

" Incannex Healthcare (ASX:IHL) makes strides in Obstructive Sleep Apnoea trial protocol

Incannex Healthcare (IHL) has advanced the protocol for its clinical trial of IHL-42X in patients with Obstructive Sleep Apnoea (OSA).
Recce Pharmaceuticals (ASX:RCE) - Non Executive Chairman, John Prendergast - The Market Herald

" Recce Pharmaceuticals’ (ASX:RCE) synthetic drugs selected for government COVID-19 program

Antibiotic maker Recce Pharmaceuticals (RCE) has had two of its key products chosen for an important government antiviral screening program to help develop
Althea Group (ASX:AGH) - CEO, Joshua Fegan - The Market Herald

" An Aussie first: Althea Group (ASX:AGH) launches online medicinal cannabis sales

In an Australian first, pharmaceutical company Althea Group (AGH) can now sell medicinal cannabis online.
MGC Pharma (ASX:MXC) - Co Founder and Managing Director, Roby Zomer - The Market Herald

" MGC Pharmaceuticals (ASX:MXC) receives import licence from Australian ODC

MGC Pharmaceuticals (MXC) has been granted an import licence by the Australian Office of Drug Control (ODC).